image
Healthcare - Medical - Devices - NASDAQ - US
$ 18.08
2.73 %
$ 691 M
Market Cap
-5.76
P/E
CASH FLOW STATEMENT
-45.8 M OPERATING CASH FLOW
-296.54%
-33.1 M INVESTING CASH FLOW
-35.04%
65.3 M FINANCING CASH FLOW
83846.15%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Orthofix Medical Inc.
image
Net Income -151 M
Depreciation & Amortization 60.6 M
Capital Expenditures -62 M
Stock-Based Compensation 35.7 M
Change in Working Capital -54 M
Others 116 K
Free Cash Flow -108 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992
OPERATING CASH FLOW
Net Income (151.4) (19.7) (38.4) 2.5 (28.5) 13.8 6.2 3.1 (2.8) (8.5) (28.5) 51.3 (1.1) 44.2 24.5 (228.6) 11.0 (7.0) 73.4 34.1 24.7 25.9 21.0 44.8 12.9 14.3 3.1 (0.5) (19.8) 9.1 7.7 6.2
Depreciation & Amortization 60.6 32.1 33.1 34.3 24.7 18.7 20.1 20.8 20.9 22.9 22.7 20.3 22.8 22.5 22.3 32.7 32.3 17.0 17.5 15.1 6.9 5.8 8.0 7.4 6.8 6.5 6.5 6.2 2.2 1.1 0.7 0.8
Deferred Income Tax 0.6 0.3 24.5 10.8 1.4 (2.7) 21.3 10.5 (1.2) (7.1) (1.2) 0.9 (0.8) 0.2 (4.4) (79.2) (12.2) (12.4) (1.5) (3.9) 0.1 1.1 (0.4) 1.0 (0.2) (5.0) (0.2) 0.3 0.3 0.2 0.5 0.6
Stock Based Compensation 35.7 18.4 15.4 16.2 21.5 18.9 12.6 16.0 7.2 5.7 6.3 6.3 6.6 8.1 10.8 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Operating Activities 62.7 (13.4) 1.9 (9.2) 42.2 8.2 10.3 6.5 3.5 5.2 31.9 54.1 21.1 (0.2) 17.0 327.8 40.2 11.5 4.5 7.1 9.7 9.8 5.4 1.3 1.8 0.3 100 K 100 K 100 K 0.4 0.3 100 K
Change in Working Capital (54.0) (29.2) (18.1) 19.7 (29.4) (7.0) (17.2) (12.1) 15.5 32.8 36.2 (121.6) 16.2 (32.4) (20.2) (27.3) (44.0) (41.5) 12.7 (25.0) (9.8) (13.3) (15.0) 1.9 (13.0) (10.1) (8.2) (9.6) (5.0) (2.3) 0.5 (4.7)
Cash From Operations (45.8) (11.5) 18.5 74.3 32.0 49.9 53.3 44.7 43.2 51.0 67.4 11.2 64.8 42.5 50.0 26.8 21.5 8.2 106.7 27.5 31.8 29.3 18.9 56.3 8.4 6.0 4.6 2.2 4.7 8.8 9.8 3.2
INVESTING CASH FLOW
Capital Expenditures (62.0) (23.2) (19.6) (17.1) (20.5) (15.3) (16.9) (18.3) (27.9) (18.5) (30.2) (28.8) (25.8) (26.4) (22.0) (20.2) (27.2) (12.6) (12.2) (12.2) (5.2) (7.1) (6.8) (5.6) (5.4) (3.4) (3.4) (3.2) (2.9) (2.5) (0.7) (0.6)
Other Items 28.9 (1.4) (3.4) (35.2) (2.4) (45.7) 0.5 (3.6) (10.4) (1.4) 0 153.8 (5.2) 24.2 (0.3) 6.2 (3.1) (342.3) 0 0.8 (150.2) (9.6) (7.9) (7.3) (5.3) 11.8 100 K (0.5) (32.0) (1.9) (6.8) (1.8)
Cash From Investing Activities (33.1) (24.5) (23.0) (52.3) (22.9) (61.0) (16.5) (21.9) (38.3) (19.9) (30.2) 125.0 (31.0) (2.1) (22.3) (13.9) (30.4) (354.9) (12.2) (11.4) (155.5) (16.8) (14.6) (12.9) (10.8) 8.4 (3.3) (3.7) (34.9) (4.4) (7.5) (2.4)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0 0 0 (63.4) (11.6) 0 (39.5) 0 0 0 (0.2) 0 0 0 0 0 (4.4) (21.9) (16.5) (2.1) (0.7) (2.1) 0 0 0 (1.2) 0 0
Total Debt Repaid 67.9 (2.6) (0.5) (0.3) (0.4) 0 0 0 0 (20.0) 16 K (190.0) (10.1) (34.5) (28.1) (24.1) (9.5) 294.1 (62.1) (33.5) 102.1 1.1 (5.0) (3.0) 5.2 (10.1) (0.3) (2.3) 15.7 (0.2) (0.4) (11.1)
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (7.8) (1.8) (11.9) (4.0) (21.9) (4.1) (4.2) (2.4) 31.4 (11.3) (2.3) 26.8 (23.7) (13.3) (1.1) 22 K 2.1 2.2 0 (0.8) (2.8) 0 0 0 0 0 (0.9) 0.2 100 K 100 K 100 K 4.4
Cash From Financing Activities 65.3 78 K (3.6) 3.2 (10.7) 3.0 3.5 (46.1) 25.1 (20.0) (38.4) (138.6) (13.7) (40.0) (29.3) (22.3) 7.7 307.8 (55.6) (22.1) 106.6 (0.3) (19.7) (2.3) 5.2 (11.7) (0.8) (1.9) 16.8 (1.2) (0.2) 14.3
CHANGE IN CASH
Net Change In Cash (12.9) (37.1) (9.0) 26.4 (1.8) (9.0) 41.6 (24.1) 26.8 7.9 (0.6) (2.2) 19.6 0.2 (1.3) (10.5) (0.8) (37.9) 37.8 (5.4) (15.3) 14.5 (16.2) 40.7 2.8 2.9 0.5 (3.4) (13.4) 3.3 2.0 14.9
FREE CASH FLOW
Free Cash Flow (107.8) (34.7) (1.1) 57.2 11.5 34.7 36.4 26.4 15.3 32.4 37.2 (17.6) 39.0 16.1 28.0 6.6 (5.7) (4.4) 94.4 15.2 26.6 22.2 12.1 50.7 3.0 2.6 1.2 (1.0) 1.8 6.3 9.1 2.6